🟢 Tempus AI, Inc. surges 10.5% after launching a digital pathology consortium with Yale and Memorial Sloan Kettering

Tempus AI, Inc. (TEM) is trading 10.5% higher today, reaching $52.50, driven by a significant new strategic initiative.

• The rally follows the company's announcement that it is launching a new open-source digital pathology consortium with Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center as founding members.
• The initiative aims to accelerate the adoption of digital pathology by developing a best-in-class open-source platform and viewer for the industry.
• To support the consortium, Tempus will contribute by open-sourcing its existing Image Management System to provide a clinical-grade baseline solution.